Axitinib Versus Placebo as an Adjuvant Treatment for Renal...

  • Main
  • 2018 / 10
  • Axitinib Versus Placebo as an Adjuvant Treatment for Renal...
Annals of Oncology 2018 / 10

Axitinib Versus Placebo as an Adjuvant Treatment for Renal Cell Carcinoma: Results From the Phase III, Randomized ATLAS Trial

Gross-Goupil, M, Kwon, T G, Eto, M, Ye, D, Miyake, H, Seo, S. I, Byun, S-S, Lee, J L, Master, V, Jin, J, DeBenedetto, R, Linke, R, Casey, M, Rosbrook, B, Lechuga, M, Valota, O, Grande, E, Quinn, D I
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy454
Date:
October, 2018
File:
PDF, 788 KB
english, 2018
Conversion to is in progress
Conversion to is failed